Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04893551
Title A Study of Tilvestamab (BGB149) in Relapsed, Platinum-resistant, High-grade Serous Ovarian Cancer (HGSOC) Participants
Recruitment Terminated
Gender female
Phase Phase I
Variant Requirements No
Sponsors BerGenBio ASA
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR


No variant requirements are available.